文献速递慢性肾脏病遗传性与小管间质肾病

常染色体隐性多囊肾病同胞兄弟的表型变异性

Phenotypic Variability in Siblings With Autosomal Recessive Polycystic Kidney Disease.
PubMed 文献 · Kidney Int Rep · 2022-05-04

该研究基于ARPKD登记研究ARegPKD,纵向随访35个家庭70例同胞兄弟,中位初诊年龄0.7岁、中位随访3.5年,发现多数幸存活过新生儿期的同胞兄弟肾脏和肝脏疾病临床过程相近,仅3对同胞兄弟肾功能病程差异明显,数据提示遗传基因型有重要影响。

要点

  • 35个家庭70例ARPKD同胞兄弟中,多数同胞兄弟肾脏和肝脏疾病临床过程相近。
  • 仅3对同胞兄弟记录到功能性肾脏疾病临床病程明显变异。
  • 70例中8例来自7个家庭在随访期间需要肾脏替代治疗(KRT)。

核心结论

  • 幸存活过新生儿期的ARPKD同胞兄弟中,多数家庭肾脏和肝脏疾病临床过程相近,数据提示遗传基因型有重要影响。

研究设计与样本

  • ARPKD登记研究ARegPKD中35对同胞兄弟的纵向临床病程分析,共70例来自35个家庭,中位初诊年龄0.7岁(四分位距0.1-6.0),中位随访3.5年(0.2-6.2)。

主要发现

  • 37例来自21个家庭的患者有PKHD1变异数据。
  • 8例来自7个家庭的患者在随访期间需要肾脏替代治疗(KRT)。
  • 44例来自26个家庭的患者记录了抗高血压治疗。
  • 37例来自24个家庭的患者有门静脉高压征象,其中9例来自6个家庭有严重肝脏并发症。
  • 仅3对同胞兄弟记录到功能性肾脏疾病临床病程明显变异;在20个新生儿存活者家庭中,17个家庭的同胞兄弟在相近年龄时肾功能仅轻微差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Autosomal recessive polycystic kidney disease (ARPKD) is a rare monogenic disorder characterized by early onset fibrocystic hepatorenal changes. Previous reports have documented pronounced phenotypic variability even among siblings in terms of patient survival. The underlying causes for this clinical variability are incompletely understood. METHODS: We present the longitudinal clinical courses of 35 sibling pairs included in the ARPKD registry study ARegPKD, encompassing data on primary manifestation, prenatal and perinatal findings, genetic testing, and family history, including kidney function, liver involvement, and radiological findings. RESULTS: We identified 70 siblings from 35 families with a median age of 0.7 (interquartile range 0.1-6.0) years at initial diagnosis and a median follow-up time of 3.5 (0.2-6.2) years. Data on PKHD1 variants were available for 37 patients from 21 families. There were 8 patients from 7 families who required kidney replacement therapy (KRT) during follow-up. For 44 patients from 26 families, antihypertensive therapy was documented. Furthermore, 37 patients from 24 families had signs of portal hypertension with 9 patients from 6 families having substantial hepatic complications. Interestingly, pronounced variability in the clinical course of functional kidney disease was documented in only 3 sibling pairs. In 17 of 20 families of our cohort of neonatal survivors, siblings had only minor differences of kidney function at a comparable age. CONCLUSION: In patients surviving the neonatal period, our longitudinal follow-up of 70 ARPKD siblings from 35 families revealed comparable clinical courses of kidney and liver diseases in most families. The data suggest a strong impact of the underlying genotype.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Ajiri R, Burgmaier K, Akinci N, et al. Phenotypic Variability in Siblings With Autosomal Recessive Polycystic Kidney Disease. Kidney Int Rep. 2022. PMID: 35812281. doi:10.1016/j.ekir.2022.04.095

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。